Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.

Suzuki, Tetsuya; Asai, Yusuke; Takahashi, Kozue; Sanada, Mio; Shimanishi, Yumiko; Terada, Mari; Sato, Lubna; Inada, Makoto; Yamada, Gen; Akiyama, Yutaro; Oshiro, Yusuke; Shiratori, Katsuyuki; Togano, Tomiteru; Takamatsu, Yuki; Kenji, Maeda; Matsunaga, Akihiro; Ishizaka, Yukihito; Nomoto, Hidetoshi; Iwamoto, Noriko; Saito, Sho; Kutsuna, Satoshi; Morioka, Shinichiro; Ohmagari, Norio

Suzuki, Tetsuya; Asai, Yusuke; Takahashi, Kozue; Sanada, Mio; Shimanishi, Yumiko; Terada, Mari; Sato, Lubna; Inada, Makoto; Yamada, Gen; Akiyama, Yutaro; Oshiro, Yusuke; Shiratori, Katsuyuki; Togano, Tomiteru; Takamatsu, Yuki; Kenji, Maeda; Matsunaga, Akihiro; Ishizaka, Yukihito; Nomoto, Hidetoshi; Iwamoto, Noriko; Saito, Sho; Kutsuna, Satoshi; Morioka, Shinichiro; Ohmagari, Norio.

Afiliação

Suzuki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Asai Y; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Takahashi K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Sanada M; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shimanishi Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Terada M; Graduate School of Public Health, Teikyo University, Tokyo, Japan.
Sato L; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Inada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yamada G; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Akiyama Y; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Oshiro Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shiratori K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Togano T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Takamatsu Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Kenji M; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan.
Matsunaga A; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan.
Ishizaka Y; Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan.
Nomoto H; Department of Refractory Viral Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Iwamoto N; Department of Refractory Viral Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Saito S; Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Kutsuna S; Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Morioka S; Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Heliyon ; 9(10): e20568, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37842585

Palavras-chave

COVID-19; convalescent plasma; emerging infectious disease; pandemic; re-emerging infectious disease

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão